Patent details

Basic Information

Publication number:

LUC50051

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP167442045

Legal Status:

Pending & Published

Application number:

LUC50051

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/25/1989

Marketing Authorization Type:

Marketing Authorization Date:

01/12/2025

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

19/04/2026

First Marketing Authorization date:

01/12/2025

Grant date:

Activation date:

Publication date:

20/04/2026

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

01/12/2040

SPC Extension Expiration:

01/12/2040

Rejection date:

Withdrawal date:

Owner

From:

19/04/2026

 

 

Name:

Momenta Pharmaceuticals, Inc.

Address:

1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

19/04/2026

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2026/06

Publication date:

04/05/2026

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

31/01/2036

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
19/04/2026	Application Form	5
19/04/2026	Outgoing Correspondence	2
19/04/2026	General Document	13
19/04/2026	General Document	37
19/04/2026	General Document	1
19/04/2026	General Document	3
20/04/2026	Outgoing Correspondence	1
20/04/2026	Publication	1